2023 annual financial data
AN2 Therapeutics 2023 Operating margin
AN2 Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -69,635,000 USD and net income was -64,732,000 USD.
Operating cash flow was -53,288,000 USD.
Get free AN2 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -69,635,000 USD
- Net income
- -64,732,000 USD
- Operating cash flow
- -53,288,000 USD